| Generic Drug/Consistency Evaluation Platform |
蟹爪兰
菊芋
榆树
郁金香
吊灯扶桑
Services and Solutions
Fukangren is committed to the research and development of new drugs and the consistency evaluation of generic drugs. It has a strong team of highly educated core personnel with rich experience in new drug R&D and industrialization.
CDMO
Focus on the development of high-end preparations and international cooperation in...
About Us
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Owns 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base
Contact Us
Sound organization, high-quality quality management team, complete document management system...
MAH Licensed Service Platform
Committed to research and development of new drugs and consistency evaluation of generic drugs
Comprehensive MAH service system
MAH policy requirements:
Holders of drug marketing permits, innovative oral membranes (MAH), need to manage the entire life cycle of drugs
Management difficulties:
Obtain production approval
Industrialization landing
Build a quality management system
Continuously improve product quality
Fukangren MAH service system:
Product development services obtained production approval
Implementation of a suitable industrial base
Quality management system construction service
Product quality improvement service
Build a joint license holding platform:
Set up a joint license company
Fukangren provides R&D industrialization platform
Fukangren provides quality management system
Partners provide sales platform
